Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
about
Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver InjuryDrug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United StatesDrug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment OptionsStem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver InjuryChinese Herbal Medicine-induced Liver InjuryDrug Induced Steatohepatitis: An Uncommon Culprit of a Common DiseasePathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South AfricaDrug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database.Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury networkEvolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges.Clinical and histologic features of azithromycin-induced liver injury.Hepatitis e virus detection in liver tissue from patients with suspected drug-induced liver injury.Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China.Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury.Prevalence and characteristics of hypoxic hepatitis in the largest single-centre cohort of avian influenza A(H7N9) virus-infected patients with severe liver impairment in the intensive care unit.Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.The etiology of hypertransaminasemia in Turkish children.Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences.Drug-induced liver injury: Do we know everything?Drug-induced liver injury: what was new in 2013?A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury.Idiosyncratic Drug Induced Liver Injury in African-Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians.Methylprednisolone-induced liver injury: Case report and literature review.Caspase 3 role and immunohistochemical expression in assessment of apoptosis as a feature of H1N1 vaccine-caused Drug-Induced Liver Injury (DILI).Pediatric acute liver failure of undetermined cause: A research workshop.The pathogenesis of drug-induced liver injury.The histopathological evaluation of drug-induced liver injury.Metabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury (DILI).Drug-induced Liver Injury: The Hepatic Pathologist's Approach.Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD).Challenges and difficulties in pathological diagnosis of autoimmune hepatitis.Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
P2860
Q26749054-28E3B502-1854-4754-B2BA-DB3F6FC048E0Q26767296-CD1BC6A2-27A8-47F5-810B-1D9E188F0F50Q26781892-07FD49DA-0245-48DC-9201-57FE949E8BA6Q26781923-54D5E8BA-63D5-4F68-B6DE-9E380271724BQ26781971-2E248E99-ED8C-4862-8121-C1B0B0201720Q26798157-3D1E826A-843C-46BF-9413-E212D63C61C8Q27690772-CF7E3A2C-A7E7-445D-8862-695A47822C4DQ28543376-FAF1A67F-6D14-47B8-B23E-7DCFC09DD998Q30241648-9E57DA90-B3B2-4586-9B65-ADACD061290FQ30852962-CB414109-36D4-446C-A19F-0DDC38DC3D14Q33946592-5EA487A8-6645-4782-AFDC-EB7A40047A4AQ34417044-3140B411-9DC1-4168-A360-FB12A5D97243Q35064690-BDBB6972-F20C-4D41-A255-BBDE0E34727CQ35229111-2346218B-3224-4566-BC08-815A08014331Q35526652-F7493B30-89A4-443A-A1ED-9644FDAE47EAQ35656015-EDFEAB2E-7C34-4A13-9C81-9860B8689668Q35771883-23D99876-3881-42DF-B4F9-EE81279D1FA0Q36405278-648494C6-8B0A-4C99-A2A2-D215FE486598Q36526484-A1BF3470-DD92-4F67-B937-FC4FB6130920Q36668300-1E7C4C12-D5C2-4945-8003-475349CB72ACQ36857771-864BCAAE-CC42-4936-9349-21938E889F37Q37625519-579E1C58-155B-4C07-A54C-18B6A8F75D84Q37635136-DF15DB1A-7284-42A6-9F72-DF1275C4BC5CQ37748005-927660C9-A403-4F34-8EBF-EC16B91A176BQ38205591-879B08F0-3E51-4E3D-91DC-6E1F760096E6Q38644395-9BCF32DE-2503-4249-8F50-E071DFAAD183Q38649906-084BF0D1-28C7-4FE9-A03D-434110B81AEAQ38671657-C9D54F65-2535-4F98-AE45-B5F3A77A8D6AQ38676495-8E2B7FBE-301E-4D21-8B6F-D39FFD92261CQ38793724-7560EE70-2C06-4698-80C2-0A6C37182EA8Q38849978-BC0A51CB-B5C4-4E63-AA1D-30136BA2DB43Q39037640-979DE844-1BD1-405A-8FEE-D95A8746E66BQ39258217-AAC4C0B0-BD70-4780-9803-F51E46EC6964Q39307576-B2BBF65C-1F94-4591-AE7A-ADB6B80E7899Q39371640-ACE52159-028B-437F-9B2B-E319CA19D40AQ39413444-1591801D-357C-4F8E-89EF-0DB16BB7C9FCQ39677764-C4E54437-2B78-46B7-8CD7-933B84C834B3Q40096207-B46F1217-F766-4A7F-AC5D-E65C15804583Q40422372-788A21FC-0BF1-4936-86DE-3B0385FD0AA0Q40425411-E3E29BC6-11EE-4A93-A47D-E2054D0EC154
P2860
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatic histological findings ...... ion and clinical associations.
@en
Hepatic histological findings ...... ion and clinical associations.
@nl
type
label
Hepatic histological findings ...... ion and clinical associations.
@en
Hepatic histological findings ...... ion and clinical associations.
@nl
prefLabel
Hepatic histological findings ...... ion and clinical associations.
@en
Hepatic histological findings ...... ion and clinical associations.
@nl
P2093
P2860
P356
P1433
P1476
Hepatic histological findings ...... ion and clinical associations.
@en
P2093
Andrew Stolz
Drug-Induced Liver Injury Network (DILIN)
Herbert L Bonkovsky
Huiman Barnhart
Jay H Hoofnagle
Jayant A Talwalkar
Jiezhun Gu
Naga P Chalasani
Paul B Watkins
Paul H Hayashi
P2860
P304
P356
10.1002/HEP.26709
P407
P577
2013-12-18T00:00:00Z